Aclarion (NASDAQ:ACON – Get Free Report) and American Well (NYSE:AMWL – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.
Earnings and Valuation
This table compares Aclarion and American Well”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Aclarion | $83,769.00 | 64.37 | -$7.23 million | ($7.40) | -0.25 |
| American Well | $249.32 million | 0.79 | -$95.70 million | ($4.77) | -2.49 |
Volatility and Risk
Aclarion has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, American Well has a beta of 1.67, suggesting that its stock price is 67% more volatile than the S&P 500.
Analyst Ratings
This is a summary of recent recommendations and price targets for Aclarion and American Well, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Aclarion | 1 | 0 | 1 | 0 | 2.00 |
| American Well | 1 | 5 | 1 | 0 | 2.00 |
Aclarion currently has a consensus price target of $7.50, indicating a potential upside of 300.86%. American Well has a consensus price target of $9.50, indicating a potential downside of 19.90%. Given Aclarion’s higher possible upside, equities research analysts plainly believe Aclarion is more favorable than American Well.
Institutional & Insider Ownership
7.5% of Aclarion shares are held by institutional investors. Comparatively, 56.0% of American Well shares are held by institutional investors. 0.0% of Aclarion shares are held by company insiders. Comparatively, 12.8% of American Well shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares Aclarion and American Well’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Aclarion | -10,948.81% | -59.34% | -56.12% |
| American Well | -35.75% | -30.12% | -22.30% |
Summary
American Well beats Aclarion on 8 of the 12 factors compared between the two stocks.
About Aclarion
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
About American Well
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
